Things have changed over the past year, not only in terms of technology but also investment. Before, it was believed that the diagnostics industry had the…
In Conversation
Now more than ever, our transformation depends on R&D
Perhaps because of the pandemic, the population has taken a closer look at their health and lifestyle, understanding that being healthy can be the difference between…
The markets I serve, in particular Africa, will start having exponential growth by the mid-21st century. Demographics, urbanization, technology, investment in infrastructure, and inter-connectivity are all…
Like many emerging markets, monetary resources are limited in the region, which makes it hard for us considering our high-tech products. Therefore, our strategy has been…
Co-creation based approaches are transforming the way R&D and innovation is being conducted with interactive processes replacing linear processes
As a company, we were fortunate to be able to provide advanced healthcare IT systems [during the COVID-19 pandemic] that provided process optimization for users, helping…
We, as Turkish Cargo, carry out our operations at top level by holding the "CEIV Pharma" certificate issued by IATA CEIV (Center of Excellence for Independent…
In Turkey NCDs account for 89 percent of all deaths with nearly one in five occurring in people under the age of 70-years
Turkey is an attractive investment destination due to its dynamic economy, young population and comprehensive national health system which covers most people living in Turkey, not…
Our advantage is due to unparalleled investment in biosimilar R&D and production; no other company in Turkey has invested as much as Arven
The [Turkish] government perceives plasma products as a strategically important product group and have developed a separate regulation and framework for them
